Free Trial
NYSE:ATR

AptarGroup Q3 2025 Earnings Report

AptarGroup logo
$132.07 -1.15 (-0.86%)
Closing price 03:59 PM Eastern
Extended Trading
$131.84 -0.23 (-0.17%)
As of 06:41 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

AptarGroup EPS Results

Actual EPS
N/A
Consensus EPS
$1.57
Beat/Miss
N/A
One Year Ago EPS
N/A

AptarGroup Revenue Results

Actual Revenue
N/A
Expected Revenue
$950.55 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

AptarGroup Announcement Details

Quarter
Q3 2025
Time
After Market Closes
Conference Call Date
Friday, October 31, 2025
Conference Call Time
9:00AM ET

Conference Call Resources

AptarGroup Earnings Headlines

KeyBanc Initiates a Buy Rating on AptarGroup (ATR)
Stunning new initiative unfolding in the White House?
what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for yourself. Once you see what’s unfolding behind the scenes, you’ll understand why I rushed this interview and opportunity to you today.tc pixel
AptarGroup (NYSE:ATR) Is Increasing Its Dividend To $0.48
See More AptarGroup Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like AptarGroup? Sign up for Earnings360's daily newsletter to receive timely earnings updates on AptarGroup and other key companies, straight to your email.

About AptarGroup

AptarGroup (NYSE:ATR) is a global provider of advanced dispensing, sealing and protection solutions for consumer and pharmaceutical markets. The company designs and manufactures a broad portfolio of products that enable the controlled delivery of liquids, gels, powders and aerosols. Its customer base spans beauty and personal care, home care, food and beverage, and pharmaceutical sectors, where innovation in packaging and drug‐delivery devices drives brand differentiation and regulatory compliance.

In the consumer markets, AptarGroup offers pumps, actuators, valves, closures and specialized bottles engineered for precision, convenience and sustainability. The company’s Beauty + Home segment delivers airless and spray packaging technologies for skincare, cosmetics, hair care and household applications. In the food and beverage arena, its solutions include dispensing caps, straws and reusable pouches designed to maintain freshness, control portioning and support on‐the‐go consumption.

AptarGroup’s Pharma segment develops drug-delivery platforms such as nasal spray pumps, metered-dose inhaler valves, soft mist inhalers and pen injectors for biologics and specialty pharmaceuticals. These devices are designed to meet stringent regulatory standards and patient safety requirements, offering reproducible dosing, user-friendly operation and compatibility with a wide range of formulations. The company also provides active packaging technologies—including barrier films and coatings—to extend shelf life and protect sensitive compounds from moisture, oxygen and light exposure.

Headquartered in Crystal Lake, Illinois, AptarGroup operates a global manufacturing and development network across North America, Europe, Latin America and Asia. Founded in 1946, the company has grown through strategic acquisitions and innovation partnerships to serve customers in more than 100 countries. As of 2024, AptarGroup is led by President and Chief Executive Officer Stephan Tanda, whose leadership focuses on driving sustainable growth, expanding research capabilities and advancing environmentally responsible packaging solutions.

View AptarGroup Profile

More Earnings Resources from MarketBeat